Bill116th CongressFiled Jul 11, 2019Health
S. 2103
Affordable Insulin Approvals Now Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Jul 11, 2019)
Affordable Insulin Approvals Now Act
This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.
What just happenedJul 11, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Who’s behind it
Sen. Durbin, Richard J. [D-IL](D-IL)Sponsor
16 cosponsors7 D9 R
16cosponsors1committees2actions1related bills5subjects
- Introduced in SenateJul 11, 2019
- Jul 11, 2019IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Health, Education, Labor, and Pensions Committee - Jul 11, 2019IntroReferral10000
Introduced in Senate